Yu Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yu Wang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chien-Wei Lin
Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, USA
3 shared publications - Yi-Guang Chen
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
2 shared publications Amber Drewek
Department of Pediatrics, Medical College of Wisconsin , Milwaukee, WI
1 shared publication- Amber Drewek
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA
1 shared publication Aron M. Geurts
Department of Physiology, Medical College of Wisconsin , Milwaukee, WI
1 shared publicationAshley E Ciecko
Department of Pediatrics, Medical College of Wisconsin , Milwaukee, WI
1 shared publication
Latest Publications
- Open Access
- 7 July 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (8)
Both soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.
CD137 is expressed in a subset of Foxp3+ regulatory CD4 T cells (Tregs), but its immunoregulatory role is not fully defined. Due to alternative splicing that removes the transmembrane domain-encoding exon, CD137 exists in both membrane and soluble forms. We investigated the function of CD137 in Foxp3+ Tregs using the NOD mouse model of type 1 diabetes (T1D). Foxp3+ Treg-specific deletion of CD137 reduced circulating soluble CD137 and accelerated T1D development, driven by heightened clonal expansion and differentiation of effector T cells in pancreatic islets. CD137 deficiency in Foxp3+ Tregs reduced their frequency in islets and impaired their differentiation toward a suppressive phenotype. Restoring soluble CD137 in Foxp3+ Tregs lacking its membrane form reduced islet T cell activation and mitigated T1D acceleration without altering the accumulation of suppressive Foxp3+ Tregs. Our results indicate that both soluble and membrane forms of CD137 expressed by Foxp3+ Tregs are critical for immunoregulation, and they independently restrain T1D development.
- 7 July 2026
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (8)
Open AccessBoth soluble and cell surface CD137 expressed by Foxp3+ CD4 T cells restrain autoimmune diabetes.
CD137 is expressed in a subset of Foxp3+ regulatory CD4 T cells (Tregs), but its immunoregulatory role is not fully defined. Due to alternative splicing that removes the transmembrane domain-encoding exon, CD137 exists in both membrane and soluble forms. We investigated the function of CD137 in Foxp3+ Tregs using the NOD mouse model of type 1 diabetes (T1D). Foxp3+ Treg-specific deletion of CD137 reduced circulating soluble CD137 and accelerated T1D development, driven by heightened clonal expansion and differentiation of effector T cells in pancreatic islets. CD137 deficiency in Foxp3+ Tregs reduced their frequency in islets and impaired their differentiation toward a suppressive phenotype. Restoring soluble CD137 in Foxp3+ Tregs lacking its membrane form reduced islet T cell activation and mitigated T1D acceleration without altering the accumulation of suppressive Foxp3+ Tregs. Our results indicate that both soluble and membrane forms of CD137 expressed by Foxp3+ Tregs are critical for immunoregulation, and they independently restrain T1D development.
- Open Access
- 2 April 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-17
A realistic FastQ-based framework FastQDesign for ScRNA-seq study design issues
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful technology for characterizing transcriptomic profiles at single-cell resolution. It is crucial to consider both the number of cells and sequencing depth during library preparation. The existing methods are primarily simulation-based, rely on Unique Molecular Identifier (UMI) matrix, and have little context in the actual FastQ reads. Here we propose the first FastQ-based study design framework, named “FastQDesign,” which leverages raw FastQ files from publicly available datasets as references and suggests an optimal design within a fixed budget. We demonstrate our framework through a synthetic dataset and applications to nine real-world datasets. Our study underscores the importance of an appropriate design to investigate the biology of heterogeneous cell populations and offers practical guidance considering cost-benefit trade-offs. A high-efficiency software suite is available at https://github.com/yuw444/FastQDesign.
- 2 April 2025
- Published by Springer Nature in Communications Biology
- Vol. 8 (1) , 1-17
Open AccessA realistic FastQ-based framework FastQDesign for ScRNA-seq study design issues
Single-cell RNA sequencing (scRNA-seq) has emerged as a powerful technology for characterizing transcriptomic profiles at single-cell resolution. It is crucial to consider both the number of cells and sequencing depth during library preparation. The existing methods are primarily simulation-based, rely on Unique Molecular Identifier (UMI) matrix, and have little context in the actual FastQ reads. Here we propose the first FastQ-based study design framework, named “FastQDesign,” which leverages raw FastQ files from publicly available datasets as references and suggests an optimal design within a fixed budget. We demonstrate our framework through a synthetic dataset and applications to nine real-world datasets. Our study underscores the importance of an appropriate design to investigate the biology of heterogeneous cell populations and offers practical guidance considering cost-benefit trade-offs. A high-efficiency software suite is available at https://github.com/yuw444/FastQDesign.
- 10 February 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (7) , 935-946
Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes
IL-21 is essential for type 1 diabetes (T1D) development in the NOD mouse model. IL-21–expressing CD4 T cells are present in pancreatic islets where they contribute to T1D progression. However, little is known about their phenotype and differentiation states. To fill this gap, we generated, to our knowledge, a novel IL-21 reporter NOD strain to further characterize IL-21+ CD4 T cells in T1D. IL-21+ CD4 T cells accumulate in pancreatic islets and recognize β cell Ags. Single-cell RNA sequencing revealed that CD4 T effector cells in islets actively express IL-21 and they are highly diabetogenic despite expressing multiple inhibitory molecules, including PD-1 and LAG3. Islet IL-21+ CD4 T cells segregate into four phenotypically and transcriptionally distinct differentiation states, that is, less differentiated early effectors, T follicular helper (Tfh)–like cells, and two Th1 subsets. Trajectory analysis predicts that early effectors differentiate into both Tfh-like and terminal Th1 cells. We further demonstrated that intrinsic IL-27 signaling controls the differentiation of islet IL-21+ CD4 T cells, contributing to their helper function. Collectively, our study reveals the heterogeneity of islet-infiltrating IL-21+ CD4 T cells and indicates that both Tfh-like and Th1 subsets produce IL-21 throughout their differentiation process, highlighting the important sources of IL-21 in T1D pathogenesis.
- 10 February 2023
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 210 (7) , 935-946
Heterogeneity of Islet-Infiltrating IL-21+ CD4 T Cells in a Mouse Model of Type 1 Diabetes
IL-21 is essential for type 1 diabetes (T1D) development in the NOD mouse model. IL-21–expressing CD4 T cells are present in pancreatic islets where they contribute to T1D progression. However, little is known about their phenotype and differentiation states. To fill this gap, we generated, to our knowledge, a novel IL-21 reporter NOD strain to further characterize IL-21+ CD4 T cells in T1D. IL-21+ CD4 T cells accumulate in pancreatic islets and recognize β cell Ags. Single-cell RNA sequencing revealed that CD4 T effector cells in islets actively express IL-21 and they are highly diabetogenic despite expressing multiple inhibitory molecules, including PD-1 and LAG3. Islet IL-21+ CD4 T cells segregate into four phenotypically and transcriptionally distinct differentiation states, that is, less differentiated early effectors, T follicular helper (Tfh)–like cells, and two Th1 subsets. Trajectory analysis predicts that early effectors differentiate into both Tfh-like and terminal Th1 cells. We further demonstrated that intrinsic IL-27 signaling controls the differentiation of islet IL-21+ CD4 T cells, contributing to their helper function. Collectively, our study reveals the heterogeneity of islet-infiltrating IL-21+ CD4 T cells and indicates that both Tfh-like and Th1 subsets produce IL-21 throughout their differentiation process, highlighting the important sources of IL-21 in T1D pathogenesis.